X C Lu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

X C Lu

Showing results (31-40 of 32) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 32 results.

Nature Medicine|December 2, 1999

Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injuryB S Slusher, J J Vornov, A G Thomas, et al.

Journal of Medicinal Chemistry|June 27, 2003

Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuriesDana Ferraris, Yao-Sen Ko, Thomas Pahutski, et al.

Pageof 4

Search research articles

Showing results (31-40 of 32) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 32 results.

Nature Medicine|December 2, 1999

Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injuryB S Slusher, J J Vornov, A G Thomas, et al.

Journal of Medicinal Chemistry|June 27, 2003

Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuriesDana Ferraris, Yao-Sen Ko, Thomas Pahutski, et al.

Pageof 4